The Lancet thelancet.com

[Seminar] Enteric (typhoid and paratyphoid) fever

thelancet.com·37w

[Seminar] Enteric (typhoid and paratyphoid) fever

thelancet.com·37w

[Articles] Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a...

thelancet.com·37w

[Articles] Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel...

thelancet.com·37w

[Articles] Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a mult...

thelancet.com·37w

[Articles] Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individua...

thelancet.com·37w

[Articles] Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, d...

thelancet.com·37w

[Comment] Milei's chainsaw health reforms in Argentina: the libertarian turn in public health

thelancet.com·37w

[Articles] Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

thelancet.com·37w

[Comment] Optional hypertension: a new concept emerging from trials of intensive blood pressure control

thelancet.com·37w

[Comment] Immediate or staged complete revascularisation in patients with ST segment elevation myocardial infarction

thelancet.com·37w

[Comment] Milei's chainsaw health reforms in Argentina: the libertarian turn in public health

thelancet.com·37w

[Comment] Evolocumab for prevention of coronary artery bypass failure: timing is everything

thelancet.com·37w

[Articles] Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, d...

thelancet.com·37w

[Comment] Evolocumab for prevention of coronary artery bypass failure: timing is everything

thelancet.com·37w

[Articles] Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

thelancet.com·37w

[Comment] Paclitaxel in the lower limbs: harm outweighs the benefit

thelancet.com·37w

[Articles] Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individua...

thelancet.com·37w

[Comment] Optional hypertension: a new concept emerging from trials of intensive blood pressure control

thelancet.com·37w

[Articles] Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel...

thelancet.com·37w

Log in to enable infinite scrolling